Financhill
Sell
24

MRNA Quote, Financials, Valuation and Earnings

Last price:
$28.34
Seasonality move :
27.14%
Day range:
$26.80 - $28.95
52-week range:
$26.80 - $170.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.44x
P/B ratio:
1.01x
Volume:
20.5M
Avg. volume:
10.4M
1-year change:
-73.4%
Market cap:
$11B
Revenue:
$3.2B
EPS (TTM):
-$9.28

Earnings Data

Next earnings date for MRNA
May 02
2025
Most recent earnings per share
-$2.91
Missed by $0.18
(Feb 14/2025)
Consensus Estimate
-$2.73
(Feb 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MRNA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $114.4M -- -- -$3.09 --
05/02/2025 Q1 $130.3M -- -- -$3.07 --
02/14/2025 Q4 $941.1M $956M -$2.91 -$2.73 -$0.18
11/07/2024 Q3 $1.2B $1.9B $0.03 -$1.94 $1.97
08/01/2024 Q2 $134.9M $221M -$3.33 -$3.36 $0.03
05/02/2024 Q1 $125.3M $167M -$3.07 -$3.55 $0.48
02/22/2024 Q4 $2.5B $2.8B $0.55 -$0.99 $1.54
11/02/2023 Q3 -- -- -$9.53 -$2.05 -$7.48
06/30/2023 Q2 -- -- -$3.62 -$4.12 $0.50
03/31/2023 Q1 -- -- $0.19 -$1.73 $1.92
12/31/2022 Q4 -- -- $3.61 $4.60 -$0.99
09/30/2022 Q3 -- -- $2.53 $3.11 -$0.58
06/30/2022 Q2 -- -- $5.24 $4.49 $0.75
03/31/2022 Q1 -- -- $8.58 -- --
12/31/2021 Q4 -- -- $11.29 -- --
09/30/2021 Q3 -- -- $7.70 -- --
06/30/2021 Q2 -- -- $6.46 -- --
03/31/2021 Q1 -- -- $2.84 -- --
12/31/2020 Q4 -- -- -$0.69 -- --
09/30/2020 Q3 -- -- -$0.59 -- --
06/30/2020 Q2 -- -- -$0.31 -- --
03/31/2020 Q1 -- -- -$0.35 -- --
12/31/2019 Q4 -- -- -$0.37 -- --
09/30/2019 Q3 -- -- -$0.37 -- --
06/30/2019 Q2 -- -- -$0.41 -- --
03/31/2019 Q1 -- -- -$0.40 -- --
12/31/2018 Q4 -- -- -$0.43 -- --
09/30/2018 Q3 -- -- -$0.27 -- --
06/30/2018 Q2 -- -- -$0.24 -- --
03/31/2018 Q1 -- -- -$0.19 -- --
12/31/2017 Q4 -- -- -$0.10 -- --

Moderna Earnings Questions

  • How Much did Moderna Generate in Revenue Last Quarter?

    Moderna reported $956M worth of top line sales in its most recent quarter.

  • Did Moderna Beat Earnings Last Quarter?

    Moderna announced earnings per share of -$2.91 which represents a miss of analyst forecast a -$2.73 per share.

  • Is Moderna Profitable?

    Moderna reported $217M that represents $0.56 per share over the last quarter.

  • What is the Analyst Consensus for Moderna EPS Next Year?

    Moderna's earnings are forecast to decrease from -$9.28 per share to -$9.03 per share next year representing a decrease of -11.15%.

  • When is Moderna's Earnings Date?

    Moderna's next earnings date is May 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is up 109.21% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.

Buy
74
COOP alert for Apr 1

Mr. Cooper Group [COOP] is up 14.4% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock